Tech Center 1600 • Art Units: 1631
This examiner grants 25% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18094851 | SYSTEMS AND METHODS TO MODEL ADAPTIVE IMMUNE RESPONSES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18194691 | ANKYRIN-RICH BTB/POZ DOMAIN-CONTAINING PROTEIN-2 (ABTB2) FOR SUPPRESSING PANCREATIC CANCER GROWTH | Non-Final OA | The Curators of the University of Missouri |
| 17716269 | CELL CULTURE FOR TREATING INFLAMMATORY DISEASE | Final Rejection | TERUMO KABUSHIKI KAISHA |
| 17996569 | GENETICALLY MANIPULATED CELL STRAIN FOR ACTIVATING AND AMPLIFYING NK CELLS AND USE THEREOF | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 18031470 | POLOXAMERS FOR CELL CULTURE | Non-Final OA | MERCK PATENT GMBH |
| 17997110 | COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY | Non-Final OA | The Trustees of the University of Pennsylvania |
| 17639962 | ADENO-ASSOCIATED VIRUS VECTOR PLATFORM FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF | Non-Final OA | University of Massachusetts |
| 18012024 | METHODS OF GENERATING HEMATOPOIETIC CELL PREPARATIONS | Non-Final OA | The Penn State Research Foundation |
| 17628913 | Targeted RNA cleavage with CRISPR-Cas | Final Rejection | University of Rochester |
| 18391547 | HIGH PRODUCTION OF RECOMBINANT PROTEIN BY MAKING CELL HYBRIDS AND ENRICHING FOR A PREFERRED MITOCHONDRIAL PHENOTYPE | Final Rejection | CHO Plus, Inc. |
| 18288146 | UV A LIGHT EXPOSURE INCREASES MITOCHONDRIAL ANTI-VIRAL PROTEIN EXPRESSION IN TRACHEAL CELLS VIA CELL-TO-CELL COMMUNICATION AND USES THEREOF | Non-Final OA | Cedars-Sinai Medical Center |
| 17599235 | MUTATED ADENO-ASSOCIATED VIRUS CAPSID PROTEINS, AAV PARTICLE COMPRISING THE SAME AND LIVER DIRECTED AAV VECTOR GENE THERAPY | Final Rejection | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. |
| 17954138 | Methods for the Storage of Whole Blood, and Compositions Thereof | Non-Final OA | Hemanext Inc. |
| 17995128 | ENHANCEMENT OF THE PRODUCTION OF ADENOVIRUS-BASED GENE TRANSFER VECTORS | Final Rejection | Greffex, Inc. |
| 17896781 | Methods and Compositions for Generating Human Forebrain Neural Progenitor Cells and for Maturation Thereof to Parvalbumin+ Interneurons | Non-Final OA | Trailhead Biosystems Inc. |
| 17793360 | CELL EXPANSION METHODS FOR PREVENTING CELL SENESCENCE AND PRESERVING THE THERAPEUTIC POTENCY OF HUMAN MESENCHYMAL STEM CELLS | Final Rejection | Timothy LOGAN |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy